Long IVMorgan Stanley Wealth ManagementAlpharettaGeorgia - State$1M$1B$2.5-10M$1-10MMatthew McWilliamsWells Fargo AdvisorsDaltonGeorgia - State$250K$256M$750K-1.6M$250K-10MJeff DrennanEdward JonesCartersvilleGeorgia - State$250K$188M$450K-4.5M$275K-3MEric FujimotoAmeriprise Financial ServicesHonoluluHawaii$2.2M$1.5B$2-10M$1.5-11MMatthew MegordenUBS Wealth ManagementHonoluluHawaii$3M$1.1B$2.7-13M$2-6MDan ShiuUBS Wealth ManagementHonoluluHawaii$250K$890M$2-5M$1-5MWang LeeMorgan Stanley Wealth ManagementHonoluluHawaii$850K$2.4B$3-10M$1.5-10MMarcus BolandBoland Wealth Management | Northwestern MutualHonoluluHawaii$500K$470M$3.5-8M$1-75MDavid ChingMorgan Stanley Wealth ManagementHonoluluHawaii$1M$2.3B$3-12M$1-10MDerek WickesMorgan Stanley Wealth ManagementHonoluluHawaii$100K$1.5B$1-5M$500K-5MGregg TakaraMorgan Stanley Wealth ManagementHonoluluHawaii$1M$1.5B$1-5M$1-5MMichael BruggemannAmeriprise Financial ServicesHonoluluHawaii$0$391M$750K-3M$100K-5MJimmy BennettMorgan Stanley Wealth ManagementHonoluluHawaii$1M$2.4B$3-10M$4.5-15MProfile SpotlightGrant KubotaMorgan Stanley Wealth ManagementHonoluluHawaii$1M$199M$4-10M$2-8MJodi ChangWells Fargo AdvisorsHonoluluHawaii$1M$251M$2-10M$1-5MJennifer RappeneckerEdward JonesKiheiHawaii$2M$373M$2-20M$1-10MJensen KonoMorgan Stanley Wealth ManagementHonoluluHawaii$500K$379M$750K-19M$400K-13MRobert SaraccoMerrill Wealth ManagementHonoluluHawaii$2M$580M$5-20M$2-10MGail HamadaAmeriprise Financial ServicesHonoluluHawaii$10K$822M$60K-7M$60K-5.5MDean A

Compared with their counterparts in the placebo group, women in the ALC group were more likely to have a greater than 5-point adjusted decrease on the neurotoxicity subscale of the Functional Assessment of Cancer TherapyTaxane (FACT-NTX) instrument at 12 weeks (odds ratio, 1.48
doi: 10.3389/fresc.2025.1648002 Received 21 June 2025 Accepted 07 October 2025 Published 24 October 2025 Volume 6 - 2025 Edited by Ines ElBini, Pasteur Institute of Tunis, Tunisia Reviewed by Himanshu Gangal, Okinawa Institute of Science and Technology Graduate University, Japan Ikram Sghaier, Tunis El Manar University, Tunisia Updates Copyright 2025 Fesharaki-Zadeh, Belliveau, Pietrzak and Arnsten
Recomendamos a utilizao do produto para pacientes de idade adulta
Cell 17 , 30513061 (2006)
10.1007/s13167-024-00377-1 190 ZhangZ.ZhangZ.LiuS.WeiS.WeiL.ZhuX.et al (2024)